Renew Your Membership

Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Cine-Med Research Institute(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Applied Therapeutics(SIGNIFICANT), STEL(MODEST), Elixir Medical(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: CONTROLRAD(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), DSI(SIGNIFICANT), Medtronic(SIGNIFICANT), OrbusNeich(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Concept Medical(SIGNIFICANT), Chiesi(SIGNIFICANT), CERC(SIGNIFICANT), Abiomed(SIGNIFICANT), CardiaWave(SIGNIFICANT), Biosensors(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Insel Gruppe AG(SIGNIFICANT), Philips(SIGNIFICANT), Arena(SIGNIFICANT), CellAegis(SIGNIFICANT), AM-Pharma(MODEST), Alleviant Medical(MODEST), CeloNova BioSciences(MODEST), Idorsia Pharmaceuticals(MODEST), BAIM(SIGNIFICANT), Biotronik(MODEST), Duke University(SIGNIFICANT), Humacyte(MODEST), Magenta(MODEST), Zoll(SIGNIFICANT), Element Science(MODEST), Janssen(SIGNIFICANT), Vivasure(MODEST) OTHER FINANCIAL BENEFIT: WebMD(SIGNIFICANT), Boston Scientific(SIGNIFICANT)

View Full Disclosure